Shekhar C Mande

CSIR India and Laxai Life Sciences Initiate Clinical Trials of Niclosamide for Treatment of Covid-19

The trial is a multi-centric, phase-II, randomized, open label clinical study to evaluate efficacy, safety and tolerability of NIclosamide for the treatment of hospitalized Covid-19 patients.